logologologo
  • Home
  • About
    • Our Team
    • News & Events
    • Careers
    • Clinical Insights & Resources
  • Patients
    • Patient Stories
    • Peripheral Nerve Stimulation
    • Resources
    • Nalu Store
  • Providers
    • Academy
    • Resources
    • Therapy Disc (TD2)
    • Product Information
  • Clinical Evidence
    • Clinical Trials
    • Real World Evidence
    • Health Economics
    • Technology
  • Contact
logologologo
  • Home
  • About
    • Our Team
    • News & Events
    • Careers
    • Clinical Insights & Resources
  • Patients
    • Patient Stories
    • Peripheral Nerve Stimulation
    • Resources
    • Nalu Store
  • Providers
    • Academy
    • Resources
    • Therapy Disc (TD2)
    • Product Information
  • Clinical Evidence
    • Clinical Trials
    • Real World Evidence
    • Health Economics
    • Technology
  • Contact
  • Home
  • About
    • Our Team
    • News & Events
    • Careers
    • Clinical Insights & Resources
  • Patients
    • Patient Stories
    • Peripheral Nerve Stimulation
    • Resources
    • Nalu Store
  • Providers
    • Academy
    • Resources
    • Therapy Disc (TD2)
    • Product Information
  • Clinical Evidence
    • Clinical Trials
    • Real World Evidence
    • Health Economics
    • Technology
  • Contact
logologologo
logologologo
  • Home
  • About
    • Our Team
    • News & Events
    • Careers
    • Clinical Insights & Resources
  • Patients
    • Patient Stories
    • Peripheral Nerve Stimulation
    • Resources
    • Nalu Store
  • Providers
    • Academy
    • Resources
    • Therapy Disc (TD2)
    • Product Information
  • Clinical Evidence
    • Clinical Trials
    • Real World Evidence
    • Health Economics
    • Technology
  • Contact

Our Evidence is Unprecedented

At Nalu, we’re setting a new standard for pain outcomes.

Nalu’s technology consistently delivers “80-50-70” results, regardless of the nerve treated.

test

80%+

of patients using Nalu

50%+

achieve 50% or more pain relief by study end

70%+

average pain reduction of Nalu Patients

We work tirelessly to help patients who are suffering from chronic intractable pain and our evidence shows proven and predictable results.

clinicaltrials
Clinical Trials

Repeated 80-50-70 results in Nalu clinical studies

evidence_2
Real-World Evidence

Consistent real-world outcomes confirming clinical study results

money
Health Economics

Improved economics for payers, patients, and society

device
Technology

Durable outcomes created by Nalu's advanced technology

Clinical Trials

Repeated 80-50-70 results in Nalu clinical studies

92%

Are very satisfied or satisfied with the system (12 months)

chart-02

COMFORT (1 Year)

A landmark clinical study for PNS

Nalu PNS was highly effective versus control regardless of treated target

87% responder rate (≥50% pain relief) with 69% average pain relief

View Clinical Evidence Resources

Real-World Evidence

Consistent real-world outcomes confirming clinical study results

4M+

Real-world data captures variability that may be missed inside a controlled setting and provides an additional perspective into patient and provider impact. With over 4M+ patient days since launch, we have a significant and growing data set.

94%

Providers: 94% agreed that successful permanent PNS may reduce opioid use

94% responder rate

Real World Evidence from 2,300+ Patients

33 different nerves and 34 nerve combinations treated

94% responder rate for MCID (PGIC)

View Real-World Resources

Health Economic Data

Improved economics for payers, patients, and society

50%

Reduction in total medical costs (1 yr pre vs 1 yr post implant)

All information is based on actual claims data as opposed to a model.

31% reduction in number of patients using opioids

22% reduction in pharmacy costs

Change in Healthcare resource utilization and costs 12 months before and 12 months after Nalu PNS implant

chart-03

Following PNS implantation, healthcare costs and opioid use were reduced compared to conventional treatment alone

61% reduction in outpatient costs

16% reduction in outpatient doctor visits

View Health Economic Resources

Technology

Durable outcomes created by Nalu's advanced technology

moa

Nalu pulse stimulation pattern waveform

Proprietary waveform designed to invoke multiple mechanisms of action from a single waveform

scheduling

Scheduling

The ability to cycle through up to four multi-area programs automatically in sequence or random order

multi-electrodes

Multi-electrodes

Multiple electrodes can be used to deliver electrical impulses to a targeted area

multi-area

Multi-area

Tonic stimulation pattern sequentially delivered in two to four areas

current-steering

Current steering

Direct electrical currents through specific electrodes to create a focused electric field in targeted areas

upgrade-system

Upgradable system

The micro-IPG software can be upgraded as new capabilities are cleared for use

chart-04

The Nalu micro-IPG has more complex programming capabilities than other PNS system

chart-05

Nalu continues to explore new and better ways to understand optimal treatment to improve patient care.

Our latest paper explores the optimal stimulation of nerves as we look to enhance patient outcomes.

View Technology Resources

Copyright © 2019-2026 Nalu Medical, Inc. All Rights Reserved.

Cookies are used on this site to collect and analyze information on performance and usage, and to enhance customer experience. By clicking “ACCEPT” or continuing to use this site, you agree to the placement of cookies on your device. To learn more, please visit our privacy policy